Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...

I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and accessibility from a state-level perspective is rough. And almost impossible.

I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

I don’t feel bad for lawmakers very often. But trying to solve the national economics of high health care costs and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Corruption and money laundering continue to undermine prospects for stability in Haiti, while enabling trafficking and ...